The Rho-Associated Kinase Inhibitor Fasudil can Replace Y-27632 for Use in Human Pluripotent Stem Cell Research
How to cite: so, S.; Lee, Y.; Park, J.; Lee, J.-Y.; Kim, D.; Hwang, J.; Shin, J.; Choi, J.; Han, Y.; Kang, S.; Dutton, J. R.; Seo, E.-J.; Lee, B. H.; Kim, C. J.; Mitalipov, S.; Oh, S.; Kang, E. The Rho-Associated Kinase Inhibitor Fasudil can Replace Y-27632 for Use in Human Pluripotent Stem Cell Research. Preprints 2019, 2019110094. https://doi.org/10.20944/preprints201911.0094.v1 so, S.; Lee, Y.; Park, J.; Lee, J.-Y.; Kim, D.; Hwang, J.; Shin, J.; Choi, J.; Han, Y.; Kang, S.; Dutton, J. R.; Seo, E.-J.; Lee, B. H.; Kim, C. J.; Mitalipov, S.; Oh, S.; Kang, E. The Rho-Associated Kinase Inhibitor Fasudil can Replace Y-27632 for Use in Human Pluripotent Stem Cell Research. Preprints 2019, 2019110094. https://doi.org/10.20944/preprints201911.0094.v1
Abstract
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)